BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27979590)

  • 1. Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS).
    Hallinger DR; Murr AS; Buckalew AR; Simmons SO; Stoker TE; Laws SC
    Toxicol In Vitro; 2017 Apr; 40():66-78. PubMed ID: 27979590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screening and chemotype-enrichment analysis of ToxCast phase II chemicals evaluated for human sodium-iodide symporter (NIS) inhibition.
    Wang J; Hallinger DR; Murr AS; Buckalew AR; Lougee RR; Richard AM; Laws SC; Stoker TE
    Environ Int; 2019 May; 126():377-386. PubMed ID: 30826616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of potential sodium-iodide symporter (NIS) inhibitors using a secondary Fischer rat thyroid follicular cell (FRTL-5) radioactive iodide uptake (RAIU) assay.
    Buckalew AR; Wang J; Murr AS; Deisenroth C; Stewart WM; Stoker TE; Laws SC
    Arch Toxicol; 2020 Mar; 94(3):873-885. PubMed ID: 32065294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a non-radioactive screening assay to detect chemicals disrupting the human sodium iodide symporter activity.
    Dong H; Atlas E; Wade MG
    Toxicol In Vitro; 2019 Jun; 57():39-47. PubMed ID: 30738889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded high-throughput screening and chemotype-enrichment analysis of the phase II: e1k ToxCast library for human sodium-iodide symporter (NIS) inhibition.
    Wang J; Richard AM; Murr AS; Buckalew AR; Lougee RR; Shobair M; Hallinger DR; Laws SC; Stoker TE
    Arch Toxicol; 2021 May; 95(5):1723-1737. PubMed ID: 33656581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Screening of ToxCast PFAS Chemical Library for Potential Inhibitors of the Human Sodium Iodide Symporter.
    Stoker TE; Wang J; Murr AS; Bailey JR; Buckalew AR
    Chem Res Toxicol; 2023 Mar; 36(3):380-389. PubMed ID: 36821091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Screening and Quantitative Chemical Ranking for Sodium-Iodide Symporter Inhibitors in ToxCast Phase I Chemical Library.
    Wang J; Hallinger DR; Murr AS; Buckalew AR; Simmons SO; Laws SC; Stoker TE
    Environ Sci Technol; 2018 May; 52(9):5417-5426. PubMed ID: 29611697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein.
    Agretti P; Dimida A; De Marco G; Ferrarini E; Rodrìguez Gonzàlez JC; Santini F; Vitti P; Pinchera A; Tonacchera M
    J Endocrinol Invest; 2011 Mar; 34(3):170-4. PubMed ID: 20479570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner.
    Vadysirisack DD; Venkateswaran A; Zhang Z; Jhiang SM
    Endocr Relat Cancer; 2007 Jun; 14(2):421-32. PubMed ID: 17639055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of triclosan, triclocarban, 2,2',4,4'-tetrabromodiphenyl ether, and bisphenol A on the iodide uptake, thyroid peroxidase activity, and expression of genes involved in thyroid hormone synthesis.
    Wu Y; Beland FA; Fang JL
    Toxicol In Vitro; 2016 Apr; 32():310-9. PubMed ID: 26827900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revision of the affinity constant for perchlorate binding to the sodium-iodide symporter based on in vitro and human in vivo data.
    Schlosser PM
    J Appl Toxicol; 2016 Dec; 36(12):1531-1535. PubMed ID: 27177048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anion selectivity by the sodium iodide symporter.
    Van Sande J; Massart C; Beauwens R; Schoutens A; Costagliola S; Dumont JE; Wolff J
    Endocrinology; 2003 Jan; 144(1):247-52. PubMed ID: 12488351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.
    Oh JM; Baek SH; Gangadaran P; Hong CM; Rajendran RL; Lee HW; Zhu L; Gopal A; Kalimuthu S; Jeong SY; Lee SW; Lee J; Ahn BC
    Thyroid; 2020 Apr; 30(4):501-518. PubMed ID: 31928162
    [No Abstract]   [Full Text] [Related]  

  • 14. A nonradioactive iodide uptake assay for sodium iodide symporter function.
    Waltz F; Pillette L; Ambroise Y
    Anal Biochem; 2010 Jan; 396(1):91-5. PubMed ID: 19733144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perchlorate transport and inhibition of the sodium iodide symporter measured with the yellow fluorescent protein variant YFP-H148Q/I152L.
    Cianchetta S; di Bernardo J; Romeo G; Rhoden KJ
    Toxicol Appl Pharmacol; 2010 Mar; 243(3):372-80. PubMed ID: 20005887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I- symporter and rat Na+/I- symporter.
    Zhang Z; Liu YY; Jhiang SM
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6131-40. PubMed ID: 16105966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
    Lakshmanan A; Wojcicka A; Kotlarek M; Zhang X; Jazdzewski K; Jhiang SM
    Endocr Relat Cancer; 2015 Feb; 22(1):11-21. PubMed ID: 25404690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluorooctane sulfonic acid, a persistent organic pollutant, inhibits iodide accumulation by thyroid follicular cells in vitro.
    Conti A; Strazzeri C; Rhoden KJ
    Mol Cell Endocrinol; 2020 Sep; 515():110922. PubMed ID: 32621861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells.
    Liu YY; Zhang X; Ringel MD; Jhiang SM
    Endocr Relat Cancer; 2012 Jun; 19(3):291-304. PubMed ID: 22355179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
    Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
    J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.